Study analysis · PLOS ONE · 2022
Your neck size might predict gestational diabetes more than your weight gain — and doctors are ignoring it.
In obese pregnant women, how old they are, if they had diabetes before, their blood pressure, and how thick their neck or back fat is predict gestational diabetes — but how much weight they gain during pregnancy doesn't.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study found that women with obesity who got gestational diabetes tended to be older, had higher blood pressure, and had thicker skinfolds or bigger necks — but it didn’t change anything to test if those things caused the diabetes. It’s like noticing that kids who eat more candy often get cavities — but that doesn’t mean candy alone causes cavities, because maybe they also don’t brush their teeth.
What’s the bottom line?
This study looked at what makes obese pregnant women more likely to get gestational diabetes — like their age, past diabetes in pregnancy, and body measurements.
How strong is this study?
This study did a really good job measuring lots of women carefully and checking their results in different ways to make sure the findings weren’t just luck. But because it didn’t randomly assign people to different treatments, we can’t be sure if the things it found are actually causing diabetes — just that they’re linked. That’s why we need to be careful not to say it 'proves' anything.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
37 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control groupno control group
- Sample size (n=1117)+19.9/20
- Follow-up+10/10
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 560 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. This is an observational cohort study with no randomization or intervention; it can identify associations but cannot rule out confounding factors or establish cause-effect relationships.
Minor COI
Minor conflicts that may slightly influence the study
The study was funded by the National Institute for Health Research (NIHR), a public funder, with no evidence of industry involvement or direct financial conflicts; however, the trial source (UPBEAT) was previously funded by multiple sources including industry, raising a minor potential for indirect bias.
Funders
Conflict Details
National Institute for Health Research (NIHR): Funded the UPBEAT trial, from which this secondary analysis was derived
Independent Analysis Safeguards
- Analysis was conducted as a secondary analysis of a previously conducted RCT with pre-specified methods
- Statistical analysis used pre-defined protocols and sensitivity analyses
- Ethics approval and informed consent were obtained through NHS Research Ethics Committee
Although the UPBEAT trial received funding from multiple sources including industry (as noted in external literature), this specific secondary analysis does not disclose industry funding or author-industry ties. The study's methodology and statistical safeguards appear robust, but the origin of the data from a trial with potential industry involvement introduces a minor, indirect bias risk.
Key takeaways
- 01
Older moms: 6% higher risk per year.
- 02
Had GDM before? Over 3x more likely.
- 03
Higher blood pressure? 34% higher risk per 10 mmHg.
- 04
Thicker skinfold on back? 12% higher risk per 5 mm.
- 05
Bigger neck? 11% higher risk per cm.
- 06
Weight gain during pregnancy? No link.
- 07
These measurements help spot high-risk women early — even before weight gain — meaning prevention should start before pregnancy, not during.
Surprising findings
- Gestational weight gain had no link to GDM risk in obese women.Every guideline and prenatal class tells women to limit weight gain to prevent GDM — but this study of over 1,100 women found zero connection.
- Neck circumference was a stronger predictor than waist circumference.Waist size is the gold standard for metabolic risk — but here, neck size outperformed it, suggesting upper-body fat is uniquely harmful in pregnancy.
- Family history of type 2 diabetes lost significance after adjusting for adiposity.We assume genetics drive GDM — but this study suggests the link is mostly through shared obesity, not direct genetic risk.
Practical takeaways
If you're obese and planning pregnancy, get your neck circumference, blood pressure, and history of prior GDM checked — and discuss pre-conception metabolic screening.
This study only applies to obese women (BMI ≥30); findings may not extend to normal-weight pregnant women.
high confidenceIf you’ve had GDM before, talk to your doctor about pre-pregnancy insulin sensitivity tests — not just weight loss.
The study didn’t test interventions — so we don’t know if reversing these markers reduces risk.
medium confidenceStop blaming yourself for gaining weight during pregnancy — this study shows it doesn’t cause GDM if you’re already obese.
Weight gain still affects other risks like preeclampsia or macrosomia — this doesn’t mean gain freely.
high confidenceWhy this study matters
Age = 6% more risk per year
For every additional year of maternal age, the risk of gestational diabetes increases by 6% — even after accounting for body fat. This suggests aging affects insulin response independently of obesity.
Most people think weight is the main culprit — but this shows biology ages differently than bodies, and older moms need earlier screening.
Past GDM? 3.27x higher risk
Women who had gestational diabetes in a prior pregnancy are over three times more likely to develop it again — even if they’re obese now. This points to lasting metabolic damage.
It’s not just about weight — it’s about your body’s memory. This means pre-pregnancy planning is critical for women with a history.
Blood pressure spikes = 34% higher risk
Every 10 mmHg rise in systolic blood pressure in early pregnancy increases GDM risk by 34% — even after adjusting for age and fat. This links vascular stress to glucose metabolism.
High blood pressure isn’t just a heart issue — it’s a red flag for insulin resistance. This could change prenatal checkups.
Neck and back fat matter more than BMI
Each 5mm increase in subscapular skinfold (back fat) raises risk by 12%, and each 1cm increase in neck circumference raises it by 11% — proving fat location beats total weight.
BMI is outdated for obese pregnant women. Measuring neck or skinfold thickness could be a cheap, non-invasive way to spot high-risk moms early.
Weight gain during pregnancy? Doesn’t matter
Gestational weight gain and changes in fat distribution between 17 and 28 weeks showed zero association with GDM risk — meaning the damage is already done before you gain weight.
This shatters the myth that losing weight during pregnancy prevents GDM. Prevention must start before conception.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
This study looked at what makes obese pregnant women more likely to get gestational diabetes — like their age, past diabetes in pregnancy, and body measurements.
Research results
Older moms: 6% higher risk per year. Had GDM before? Over 3x more likely. Higher blood pressure? 34% higher risk per 10 mmHg. Thicker skinfold on back? 12% higher risk per 5 mm. Bigger neck? 11% higher risk per cm. Weight gain during pregnancy? No link.
What this means - more context
These measurements help spot high-risk women early — even before weight gain — meaning prevention should start before pregnancy, not during.
This study assessed clinical and anthropometric risk factors for gestational diabetes mellitus (GDM) in pregnant women with obesity.
In obese pregnant women, early pregnancy age, previous GDM, systolic blood pressure, subscapular skinfold thickness, and neck circumference were independently associated with increased GDM risk, while gestational weight gain and changes in adiposity measures were not.
Methods Used
Secondary analysis of 1117 obese pregnant women from the UPBEAT trial; multivariable logistic regression assessed associations between early second-trimester clinical and anthropometric measures (age, blood pressure, skinfold thickness, neck/waist circumference) and GDM diagnosis via OGTT at 24–28 weeks.
Main Finding
Each year of maternal age increased GDM risk by 6% (adj OR 1.06), previous GDM increased risk 3.27-fold, each 10 mmHg rise in systolic BP increased risk by 34% (adj OR 1.34), each 5 mm increase in subscapular skinfold increased risk by 12% (adj OR 1.12), and each 1 cm increase in neck circumference increased risk by 11% (adj OR 1.11); gestational weight gain and adiposity changes were not associated with GDM.
Confidence Level
High confidence due to large sample size (n=1117), multivariable adjustment for confounders, sensitivity analyses with imputed data and outlier exclusion confirming results, and use of standardized IADPSG criteria for GDM diagnosis.
Study Flags
Red Flags
- •Secondary analysis of an RCT with potential selection bias
- •Anthropometric measures not standardized across all sites
- •Gestational age at OGTT varied (23–32 weeks), though not differing between groups
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Gestational weight gain had no link to GDM risk in obese women.
Every guideline and prenatal class tells women to limit weight gain to prevent GDM — but this study of over 1,100 women found zero connection.
Practical Takeaways
If you're obese and planning pregnancy, get your neck circumference, blood pressure, and history of prior GDM checked — and discuss pre-conception metabolic screening.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 560 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Moderate probability
on the GRADE evidence scale
This study found that women with obesity who got gestational diabetes tended to be older, had higher blood pressure, and had thicker skinfolds or bigger necks — but it didn’t change anything to test if those things caused the diabetes. It’s like noticing that kids who eat more candy often get cavities — but that doesn’t mean candy alone causes cavities, because maybe they also don’t brush their teeth.
Minor conflicts detected — such as academic funding or advisory roles. These are common and have a small score impact.
Strengths
- Large sample size (n=1117) with high statistical power
- Use of standardized, validated anthropometric measurements by trained staff
- Clear diagnostic criteria for GDM (IADPSG)
Weaknesses
- No randomization or intervention — observational design limits causal inference
- Blinding status unknown — potential for measurement or assessment bias
- Secondary analysis of an RCT cohort — selection bias from original trial recruitment (only 1555/8820 enrolled)
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
This study looked at what makes obese pregnant women more likely to get gestational diabetes — like their age, past diabetes in pregnancy, and body measurements.
Research results
Older moms: 6% higher risk per year. Had GDM before? Over 3x more likely. Higher blood pressure? 34% higher risk per 10 mmHg. Thicker skinfold on back? 12% higher risk per 5 mm. Bigger neck? 11% higher risk per cm. Weight gain during pregnancy? No link.
What this means - more context
These measurements help spot high-risk women early — even before weight gain — meaning prevention should start before pregnancy, not during.
This study assessed clinical and anthropometric risk factors for gestational diabetes mellitus (GDM) in pregnant women with obesity.
In obese pregnant women, early pregnancy age, previous GDM, systolic blood pressure, subscapular skinfold thickness, and neck circumference were independently associated with increased GDM risk, while gestational weight gain and changes in adiposity measures were not.
Methods Used
Secondary analysis of 1117 obese pregnant women from the UPBEAT trial; multivariable logistic regression assessed associations between early second-trimester clinical and anthropometric measures (age, blood pressure, skinfold thickness, neck/waist circumference) and GDM diagnosis via OGTT at 24–28 weeks.
Main Finding
Each year of maternal age increased GDM risk by 6% (adj OR 1.06), previous GDM increased risk 3.27-fold, each 10 mmHg rise in systolic BP increased risk by 34% (adj OR 1.34), each 5 mm increase in subscapular skinfold increased risk by 12% (adj OR 1.12), and each 1 cm increase in neck circumference increased risk by 11% (adj OR 1.11); gestational weight gain and adiposity changes were not associated with GDM.
Confidence Level
High confidence due to large sample size (n=1117), multivariable adjustment for confounders, sensitivity analyses with imputed data and outlier exclusion confirming results, and use of standardized IADPSG criteria for GDM diagnosis.
Study Flags
Red Flags
- •Secondary analysis of an RCT with potential selection bias
- •Anthropometric measures not standardized across all sites
- •Gestational age at OGTT varied (23–32 weeks), though not differing between groups
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Gestational weight gain had no link to GDM risk in obese women.
Every guideline and prenatal class tells women to limit weight gain to prevent GDM — but this study of over 1,100 women found zero connection.
Practical Takeaways
If you're obese and planning pregnancy, get your neck circumference, blood pressure, and history of prior GDM checked — and discuss pre-conception metabolic screening.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 560 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Moderate probability
on the GRADE evidence scale
This study found that women with obesity who got gestational diabetes tended to be older, had higher blood pressure, and had thicker skinfolds or bigger necks — but it didn’t change anything to test if those things caused the diabetes. It’s like noticing that kids who eat more candy often get cavities — but that doesn’t mean candy alone causes cavities, because maybe they also don’t brush their teeth.
Minor conflicts detected — such as academic funding or advisory roles. These are common and have a small score impact.
Strengths
- Large sample size (n=1117) with high statistical power
- Use of standardized, validated anthropometric measurements by trained staff
- Clear diagnostic criteria for GDM (IADPSG)
Weaknesses
- No randomization or intervention — observational design limits causal inference
- Blinding status unknown — potential for measurement or assessment bias
- Secondary analysis of an RCT cohort — selection bias from original trial recruitment (only 1555/8820 enrolled)
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This study did a really good job measuring lots of women carefully and checking their results in different ways to make sure the findings weren’t just luck. But because it didn’t randomly assign people to different treatments, we can’t be sure if the things it found are actually causing diabetes — just that they’re linked. That’s why we need to be careful not to say it 'proves' anything.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
37 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control groupno control group
- Sample size (n=1117)+19.9/20
- Follow-up+10/10
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 560 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. This is an observational cohort study with no randomization or intervention; it can identify associations but cannot rule out confounding factors or establish cause-effect relationships.
Minor COI
Minor conflicts that may slightly influence the study
The study was funded by the National Institute for Health Research (NIHR), a public funder, with no evidence of industry involvement or direct financial conflicts; however, the trial source (UPBEAT) was previously funded by multiple sources including industry, raising a minor potential for indirect bias.
Funders
Conflict Details
National Institute for Health Research (NIHR): Funded the UPBEAT trial, from which this secondary analysis was derived
Independent Analysis Safeguards
- Analysis was conducted as a secondary analysis of a previously conducted RCT with pre-specified methods
- Statistical analysis used pre-defined protocols and sensitivity analyses
- Ethics approval and informed consent were obtained through NHS Research Ethics Committee
Although the UPBEAT trial received funding from multiple sources including industry (as noted in external literature), this specific secondary analysis does not disclose industry funding or author-industry ties. The study's methodology and statistical safeguards appear robust, but the origin of the data from a trial with potential industry involvement introduces a minor, indirect bias risk.
Standing
The people behind it
The researchers who wrote the study this analysis is built on.
Authored by
7 researchersIf this is your work, this is how we attribute it on Fit Body Science. Sara L. White is listed as the lead author.